You have 9 free searches left this month | for more free features.

endometrial gene profile

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Poor Response to Ovulation Induction Trial (Lutropin alfa, Follitropin alfa, Endometrial biopsy)

Not yet recruiting
  • Poor Response to Ovulation Induction
  • Lutropin alfa
  • +2 more
  • (no location specified)
Jun 8, 2022

Endometrial Cancer Trial (Paclitaxel, Carboplatin, Cisplatin)

Not yet recruiting
  • Endometrial Cancer
  • (no location specified)
Aug 4, 2022

Resected Pancreatic and Ampullary Adenocarcinoma at Favorable

Enrolling by invitation
  • Resectable Pancreatic Adenocarcinoma
    • Milan, Italy
      National Cancer Institute of Milan
    Mar 3, 2023

    Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Endometrial Adenocarcinoma Trial in Houston (Copanlisib,

    Recruiting
    • Deleterious BRCA1 Gene Mutation
    • +10 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 23, 2022

    Endometrial Cancer Trial (Letrozole 2.5mg)

    Not yet recruiting
    • Endometrial Cancer
    • Letrozole 2.5mg
    • (no location specified)
    Jul 26, 2022

    Advanced NSCLC Trial in China (Gene Profile explore)

    Recruiting
    • Advanced NSCLC
    • Gene Profile explore
    • Beijing, China
    • +14 more
    Jan 27, 2023

    Donor Derived Cell Free DNA and Histopathology in Kidney

    Not yet recruiting
    • Transplant;Failure,Kidney
    • +2 more
      • (no location specified)
      Apr 11, 2023

      Genome Instability, Genetic Predisposition to Disease, Gene Rearrangement Trial in Rome (Diagnostic Test)

      Recruiting
      • Genome Instability
      • +2 more
      • Diagnostic Test
      • Rome, Italy
        Fondazione Policlinico Universitario Agostino Gemelli IRCCS
      Aug 30, 2023

      Regional Nodal Basins and Gene Expression Profiling in Primary

      Not yet recruiting
      • Cutaneous Squamous Cell Carcinoma of the Head and Neck
      • Ultrasound
      • 40-GEP
      • (no location specified)
      Jul 12, 2023

      High-Risk Breast Duct Epithelium

      Completed
      • Breast Cancer
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 8, 2023

        Urinary Uromodulin and Corresponding Urinary Exosomal UMOD mRNA

        Completed
        • Diabetic Nephropathy, Urinary Uromodulin, Exosomal UMOD mRNA Gene Expression
        • ACR, fasting, postprandial blood glucose ,HbA1c, creatinine, cystatin-C, BUN, Na, K , lipid profile
        • Tanta, Al Gharbia, Egypt
          Tanta university hospital, faculty of science, tanta university
        Jan 24, 2023

        Blood Biomarkers in Pediatric Kidney Transplant Recipients

        Not yet recruiting
        • Rejection of Kidney Allograft
        • Observational group
        • Minneapolis, Minnesota
          University of Minnesota
        Jul 25, 2022

        BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)

        Active, not recruiting
        • BRCA1 Gene Mutation
        • +9 more
        • Laboratory Biomarker Analysis
        • +3 more
        • Columbus, Ohio
          Ohio State University Comprehensive Cancer Center
        Sep 16, 2022

        Factors Influencing Cascade Testing Among Hereditary

        Recruiting
        • Breast Carcinoma
        • +8 more
        • Interview
        • +2 more
        • Birmingham, Alabama
        • +1 more
        Jun 22, 2022

        Endometrial Cancer Trial (Excise adipose tissue)

        Not yet recruiting
        • Endometrial Cancer
        • Excise adipose tissue
        • (no location specified)
        Aug 18, 2021

        Genetic Profile in Patients With Aortic Syndrome

        Completed
        • Gene Abnormality
        • Acute Aortic Syndrome
        • genetic analysis
        • Sevilla, Andalucia, Spain
        • +1 more
        Apr 21, 2022

        Cancer, Advanced Cancer, Advanced Solid Tumor Trial (Drug-Drug Interaction Profile, Drug-Gene Interaction Profile, Standard of

        Not yet recruiting
        • Cancer
        • +2 more
        • Drug-Drug Interaction Profile
        • +2 more
        • (no location specified)
        Dec 8, 2021

        Cutaneous Melanoma Trial in Atlanta, Louisville, Saint Louis

        Terminated
        • Cutaneous Melanoma
          • Atlanta, Georgia
          • +2 more
          Oct 1, 2021

          Postmenopausal Women Trial (tibolone, Tibolone 2.5 mg, CE/MPA)

          Completed
          • Postmenopausal Women
          • (no location specified)
          Feb 2, 2022

          Gene Expression in Chronic Venous Leg Ulcers

          Recruiting
          • Genetic Predisposition to Disease
          • +2 more
          • Genetic assessment
          • Catanzaro, Italy
            University Magna Graecia of Catanzaro
          Nov 14, 2021

          Pre Diabetes Trial in Bogotá (Nasturtium (Tropaeolum majus), Placebo)

          Completed
          • Pre Diabetes
          • Nasturtium (Tropaeolum majus)
          • Placebo
          • Bogotá, Cundinamarca, Colombia
            Hospital Universitario San Ignacio
          Apr 23, 2022

          Endometrial Cancer Stage I, Endometrial Cancer Stage II Trial in Worldwide (Vaginal brachytherapy, External beam radiotherapy,

          Recruiting
          • Endometrial Cancer Stage I
          • Endometrial Cancer Stage II
          • Vaginal brachytherapy
          • +2 more
          • Vienna, Austria
          • +30 more
          Aug 16, 2021

          Soft Tissue Sarcoma, Advanced Cancer, Metastatic Cancer Trial in France (Blood and tumor samples)

          Recruiting
          • Soft Tissue Sarcoma
          • +2 more
          • Blood and tumor samples
          • Clermont-Ferrand, France
          • +9 more
          Dec 8, 2021

          Molecular Classification of Relapsed/Refractory Diffuse Large

          Completed
          • Lymphoma, Large B-Cell, Diffuse
          • Gene Expression Profiling
          • Gene expression profile
          • Shanghai, Shanghai, China
            Yian Zhang
          Mar 31, 2022

          Advanced Endometrial Cancer, Cervical Cancer and Ovarian Cancer Trial in China (TQ-B3525 tablet)

          Recruiting
          • Advanced Endometrial Cancer, Cervical Cancer and Ovarian Cancer
          • TQ-B3525 tablet
          • Changzhou, Jiangsu, China
          • +4 more
          May 27, 2021